• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Cancer mutation precision medicine oncology targeted
Biotech

BIO 2026: How a gut feeling transformed cancer treatment forever

“Some people thought we were deluded,” Israel Lowy, M.D., Ph.D., said. “But we felt there was something there, and we needed to keep at it."
Will Maddox Jun 25, 2026 9:23am
layoffs layoff exit cut employees staff downsize workforce reduction

Biogen ends Apellis research programs, cuts roles after buyout

Jun 26, 2026 9:56am
ipsen-heropng

Redefining PSC success through endpoint research.

Brought to you by Ipsen
Graphic for The Top Line podcast featuring a pale blue background with a repeating pattern of blue-and-white capsules a

The deal before the deal

Jun 26, 2026 9:20am
For biopharma manufacturing at speed and scale the future is flexible

For biopharma manufacturing at speed and scale, the future is flexible

Brought to you by Resilience
Moderna

Moderna enters in vivo CAR-T with autoimmune asset

Jun 26, 2026 9:00am
More News

EMD Serono taps in new commercial strategy head—Chutes & Ladders

Jun 26, 2026 8:30am

iBio champions AI-fueled obesity pivot as 1st asset hits clinic

Jun 26, 2026 5:00am
Fierce Pharma

Fosun Pharma plots global push, fueled by Alzheimer’s deals

Jun 25, 2026 7:00pm

Otsuka posts phase 3b ADHD trial win ahead of looming FDA ruling

Jun 25, 2026 9:13am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings